| Autor: |
Koch, F., Salva, K.A., Wirtz, M., Hadaschik, E., Varaljai, R., Schadendorf, D., Roesch, A. |
| Předmět: |
|
| Zdroj: |
Journal of the European Academy of Dermatology & Venereology; Dec2020, Vol. 34 Issue 12, pe844-e846, 3p |
| Abstrakt: |
Efficacy of cold atmospheric plasma vs. diclofenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater-blinded study (ACTICAP) I Dear Editor, i Actinic keratoses (AK) represent the most common skin malignancy worldwide and are considered the earliest stage in cutaneous squamous cell carcinoma development. The median total number of AKs in the CAP arm and in the diclofenac arm at baseline were seven AKs (CAP; range 2-17) and six AKs (diclofenac; range 3-15). [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text